Skip to main content
OpenTrials
Completed

NCT Number: NCT02292797

Assessment of the Rosacea Prevalence in the General Population

Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

About this study

Primary objective:

Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Part I

Inclusion criteria

The following subjects will be included in the study:

  • Subjects aged 18 to 65 years old from the general population
  • Subjects who are willing to complete the questionnaires

Part II

Inclusion criteria

The following subjects will be included in Part II of the study:

  • Subjects who screened positive for rosacea during the first part of the study and selected by random method
  • Subjects who gave their informed consent to participate in Part II of the study

Treatment and study plan

Prevalence assessment

Other

Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis

Primary outcomes

  1. percentage of subjects with rosacea diagnosis confirmed

    Time frame: general population will be surveyed over an expected average duration of 6 months

    estimation of the percentage of rosacea patients in the general population

Sponsors and collaborators

Lead sponsor

Galderma R&D

Industry

Registry information

Official study title

Assessment of the Prevalence of Rosacea in the General Population

Acronym: RISE

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Nov 17, 2014
Registry last updated
Nov 17, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.